statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	822
GB - Regno Unito	273
CN - Cina	257
SG - Singapore	215
IT - Italia	139
SE - Svezia	89
DE - Germania	88
BD - Bangladesh	65
BR - Brasile	64
FR - Francia	61
RU - Federazione Russa	59
IN - India	46
HK - Hong Kong	42
VN - Vietnam	40
ES - Italia	37
IE - Irlanda	36
JP - Giappone	31
CA - Canada	26
NL - Olanda	26
TR - Turchia	23
FI - Finlandia	17
PL - Polonia	16
CI - Costa d'Avorio	12
GR - Grecia	12
KR - Corea	12
MX - Messico	11
DK - Danimarca	10
ID - Indonesia	10
AR - Argentina	8
BE - Belgio	7
RO - Romania	6
UA - Ucraina	6
AT - Austria	5
AU - Australia	5
CH - Svizzera	5
CO - Colombia	5
IR - Iran	5
KZ - Kazakistan	5
PT - Portogallo	5
TN - Tunisia	5
VE - Venezuela	5
IL - Israele	4
MA - Marocco	4
QA - Qatar	4
UZ - Uzbekistan	4
ZA - Sudafrica	4
CU - Cuba	3
PE - Perù	3
AE - Emirati Arabi Uniti	2
AM - Armenia	2
BB - Barbados	2
BG - Bulgaria	2
BW - Botswana	2
DZ - Algeria	2
JO - Giordania	2
KE - Kenya	2
LT - Lituania	2
LU - Lussemburgo	2
NO - Norvegia	2
PR - Porto Rico	2
RS - Serbia	2
AZ - Azerbaigian	1
BN - Brunei Darussalam	1
CL - Cile	1
CR - Costa Rica	1
CZ - Repubblica Ceca	1
EC - Ecuador	1
ET - Etiopia	1
GT - Guatemala	1
HR - Croazia	1
HU - Ungheria	1
IQ - Iraq	1
JM - Giamaica	1
MK - Macedonia	1
PH - Filippine	1
PK - Pakistan	1
SA - Arabia Saudita	1
SC - Seychelles	1
SK - Slovacchia (Repubblica Slovacca)	1
TT - Trinidad e Tobago	1
ZM - Zambia	1
Totale	2.683

Nome	#
Balò’s concentric sclerosis : still to be considered as a variant of multiple sclerosis?	538
The novel GRN g.1159-1160delTG mutation is associated with behavioral variant frontotemporal dementia	339
CSF β-amyloid and white matter damage: A new perspective on Alzheimer's disease	226
CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis	225
Word and Picture Version of the Free and Cued Selective Reminding Test (FCSRT): Is There Any Difference?	206
C9ORF72 repeat expansion not detected in patients with multiple sclerosis	200
Evidence of CNS β-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation	185
Effect of fingolimod treatment on circulating miR-15b, miR23a and miR-223 levels in patients with multiple sclerosis	184
Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosis	182
Partial recovery after severe immune reconstitution inflammatory syndrome in a multiple sclerosis patient with progressive multifocal leukoencephalopathy	175
Merkel cell carcinoma in a patient with relapsing-remitting multiple sclerosis treated with fingolimod	173
Expression and genetic analysis of microRNAs involved in multiple sclerosis	161
null	3
Totale	2.797

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	43	0	0	0	0	0	0	0	0	0	0	0	43
2021/2022	192	16	18	3	9	11	17	10	12	26	26	13	31
2022/2023	271	30	36	27	26	16	41	9	25	32	4	15	10
2023/2024	222	9	11	12	16	50	17	11	21	10	22	17	26
2024/2025	462	13	43	4	52	65	32	24	42	18	42	39	88
2025/2026	859	96	43	59	83	62	50	60	30	113	56	140	67
Totale													2.797

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca